Key result
Advanced Virus Detection Technologies Interest Group forms to share high throughput sequencing data.
Describes the formation and goals of the Advanced Virus Detection Technologies Interest Group to facilitate the use of high throughput sequencing for virus detection.
Supports collaborative development of sequencing-based virus detection in biologics; leaves open standardization and regulatory validation needs.
Several nucleic-acid based technologies have recently emerged with capabilities for broad virus detection. One of these, high throughput sequencing, has the potential for novel virus detection because this method does not depend upon prior viral sequence knowledge. However, the use of high throughput sequencing for testing biologicals poses greater challenges as compared to other newly introduced tests due to its technical complexities and big data bioinformatics. Thus, the Advanced Virus Detection Technologies Users Group was formed as a joint effort by regulatory and industry scientists to facilitate discussions and provide a forum for sharing data and experiences using advanced new virus detection technologies, with a focus on high throughput sequencing technologies. The group was initiated as a task force that was coordinated by the Parenteral Drug Association and subsequently became the Advanced Virus Detection Technologies Interest Group to continue efforts for using new technologies for detection of adventitious viruses with broader participation, including international government agencies, academia, and technology service providers.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2016) studied Virus detection. High throughput sequencing (HTS) was evaluated. The Advanced Virus Detection Technologies Interest Group was formed to facilitate discussions and share data on using high throughput sequencing for adventitious virus detection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: